Published in Drug Discov Today on January 01, 2001
Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci (2007) 4.39
Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J (2007) 2.38
Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst (2009) 1.73
Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed. J Thorac Oncol (2013) 1.04
Size Controlled Synthesis of Monodispersed, Core/Shell Nanogels. Colloid Polym Sci (2008) 1.00
Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications. Mol Membr Biol (2010) 0.96
Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype. J Ovarian Res (2008) 0.95
Phase and size controllable synthesis of NaYbF4 nanocrystals in oleic acid/ionic liquid two-phase system for targeted fluorescent imaging of gastric cancer. Theranostics (2013) 0.93
Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions. RNA (2008) 0.92
Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. J Mater Chem (2010) 0.90
Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells. Int J Pharm (2007) 0.89
Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting. Eur J Nucl Med Mol Imaging (2006) 0.86
Phototriggerable liposomes: current research and future perspectives. Pharmaceutics (2013) 0.86
Prospects in folate receptor-targeted radionuclide therapy. Front Oncol (2013) 0.83
In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer. Eur J Nucl Med Mol Imaging (2006) 0.83
Folate-targeted polymeric micelles loaded with ultrasmall superparamagnetic iron oxide: combined small size and high MRI sensitivity. Int J Nanomedicine (2012) 0.82
Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors. Int J Nanomedicine (2014) 0.82
Development of new folate-based PET radiotracers: preclinical evaluation of ⁶⁸Ga-DOTA-folate conjugates. Eur J Nucl Med Mol Imaging (2010) 0.82
Folic acid-CdTe quantum dot conjugates and their applications for cancer cell targeting. Cancer Nanotechnol (2010) 0.81
Evaluation of cytotoxicity and mechanism of apoptosis of doxorubicin using folate-decorated chitosan nanoparticles for targeted delivery to retinoblastoma. Cancer Nanotechnol (2010) 0.80
Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate. Sci Rep (2016) 0.80
The therapeutic effect of methotrexate-conjugated Pluronic-based polymeric micelles on the folate receptor-rich tumors treatment. Int J Nanomedicine (2015) 0.79
mRNA instability in the nucleus due to a novel open reading frame element is a major determinant of the narrow tissue specificity of folate receptor alpha. Mol Cell Biol (2003) 0.79
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma. Int J Nanomedicine (2016) 0.77
Multifunctional nanoassemblies of block copolymers for future cancer therapy. Sci Technol Adv Mater (2010) 0.77
Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptor. Oncoimmunology (2015) 0.77
Cryptophane-folate biosensor for (129)xe NMR. Bioconjug Chem (2014) 0.77
18 F-click labeling and preclinical evaluation of a new 18 F-folate for PET imaging. EJNMMI Res (2013) 0.76
Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.76
New p32/gC1qR Ligands for Targeted Tumor Drug Delivery. Chembiochem (2016) 0.76
Receptor-Mediated Drug Delivery Systems Targeting to Glioma. Nanomaterials (Basel) (2015) 0.75
A RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy. Sci Rep (2016) 0.75
Promising Nanocarriers for PEDF Gene Targeting Delivery to Cervical Cancer Cells Mediated by the Over-expressing FRα. Sci Rep (2016) 0.75
Fabrication of RNA 3D Nanoprisms for Loading and Protection of Small RNAs and Model Drugs. Adv Mater (2016) 0.75
Multi-functionalized carbon dots as theranostic nanoagent for gene delivery in lung cancer therapy. Sci Rep (2016) 0.75
Biopolymer based nanosystem for doxorubicin targeted delivery. Am J Cancer Res (2017) 0.75
Folate-conjugated boron nitride nanospheres for targeted delivery of anticancer drugs. Int J Nanomedicine (2016) 0.75
A phase I and pharmacokinetic study of the nonpolyglutamatable thymidylate synthase inhibitor ZD9331 plus docetaxel in patients with advanced solid malignancies. Invest New Drugs (2004) 0.75
Development of a New Folate-Derived Ga-68-Based PET Imaging Agent. Mol Imaging Biol (2017) 0.75